Form4insider filings, from the source

SEC Form 4 · accession 0001808343-26-000009

Immunome Inc. · IMNM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 6, 2026
Accepted (ET)
Aug 10, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001472012

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Aug 6, 2026S20,840$26.06D87,664ISee footnote
Common StockF4,F3Aug 7, 2026S15,248$26.06D72,416ISee footnote
Common Stockholding———103,259D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses